Merck's Venture Arm Leads $7.3M Seed Round in Precision Chroma
Merck's venture arm has led a $7.3 million seed round into New Zealand biotech Precision Chroma, marking a major pharma investor's early bet on the company.
Topic
Merck
Topic
Topic
Topic
Merck's venture arm has led a $7.3 million seed round into New Zealand biotech Precision Chroma, marking a major pharma investor's early bet on the company.